Riskpilot← Back to searchSign inGet full accessMedShape Sverige AB
ABActiveOrg 5591942627Västra Storgatan 62Beauty care and other beauty treatment activities · NACE 9622Est. 20191-4 employees
Revenue 2024
SEK 3,4M
+2% vs 2023
EBITDA margin
4.6%
+121% vs 2023
Equity ratio
32.0%
Financial strength
Net profit 2024
SEK 133K
+2689% vs 2023
| Revenue | SEK 3,4M | +2% |
| EBITDA | SEK 155K | +121% |
| Net profit | SEK 133K | +2689% |
| Total assets | SEK 1,4M | -3% |
| Equity | SEK 452K | +42% |
| Employees | — | — |
Legal name
MedShape Sverige AB
Org number
5591942627
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
8 februari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utföra skönhetsbehandlingar och massagebehandlingar och därmed förenlig verksamhet.
Address
Västra Storgatan 62
Email
info@medshape.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 885 | 2 907 | 2 819 | 3 290 | 3 368 |
| Staff expenses | — | — | — | −1 581 | −1 771 |
| EBITDA | 318 | 139 | 158 | 70 | 155 |
| Depreciation & amort. | −49 | −63 | −65 | −71 | −53 |
| EBIT | 269 | 76 | 93 | −2 | 102 |
| Net financials | −10 | −4 | −4 | 9 | 14 |
| Profit before tax | 177 | 79 | 106 | 7 | 106 |
| Tax | −39 | −19 | −25 | −3 | 27 |
| Net profit | 138 | 60 | 81 | 5 | 133 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 063 | 1 136 | 1 082 | 1 457 | 1 412 |
| Equity | 234 | 294 | 315 | 320 | 452 |
| Long-term debt | 77 | 33 | 31 | 31 | 1 |
| Short-term debt | 625 | 690 | 633 | 1 002 | 844 |
| Total debt | 702 | 723 | 664 | 1 033 | 845 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20202024
Equity ratio
32.0%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
29.4%
This company
18.4%
Market median
+60% vs market
20202024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20202024
Asset turnover
2.39×
This company
1.12×
Market median
+113% vs market
20202024
Debt / equity
2.12×
This company
0.62×
Market median
-242% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EU Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedShape Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Ulla Linnéa Vahlqvist Alderin | Chief Executive Officer | 0 companies |
| Erik Krister Mikael Wittbom | Deputy Board Member | 0 companies |
| Maans Åke Wilhelm Alderin | Deputy Board Member | 0 companies |